1-247424106-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001243133.2(NLRP3):​c.657C>T​(p.Thr219=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0689 in 1,613,902 control chromosomes in the GnomAD database, including 5,177 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1291 hom., cov: 31)
Exomes 𝑓: 0.065 ( 3886 hom. )

Consequence

NLRP3
NM_001243133.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -10.6
Variant links:
Genes affected
NLRP3 (HGNC:16400): (NLR family pyrin domain containing 3) This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 1-247424106-C-T is Benign according to our data. Variant chr1-247424106-C-T is described in ClinVar as [Benign]. Clinvar id is 259562.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-247424106-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-10.6 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.209 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NLRP3NM_001243133.2 linkuse as main transcriptc.657C>T p.Thr219= synonymous_variant 4/10 ENST00000336119.8 NP_001230062.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NLRP3ENST00000336119.8 linkuse as main transcriptc.657C>T p.Thr219= synonymous_variant 4/101 NM_001243133.2 ENSP00000337383 P1

Frequencies

GnomAD3 genomes
AF:
0.110
AC:
16651
AN:
151920
Hom.:
1290
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.213
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.0920
Gnomad ASJ
AF:
0.0758
Gnomad EAS
AF:
0.146
Gnomad SAS
AF:
0.0528
Gnomad FIN
AF:
0.0880
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.0579
Gnomad OTH
AF:
0.103
GnomAD3 exomes
AF:
0.0802
AC:
20156
AN:
251268
Hom.:
1098
AF XY:
0.0755
AC XY:
10254
AN XY:
135788
show subpopulations
Gnomad AFR exome
AF:
0.218
Gnomad AMR exome
AF:
0.0847
Gnomad ASJ exome
AF:
0.0805
Gnomad EAS exome
AF:
0.143
Gnomad SAS exome
AF:
0.0451
Gnomad FIN exome
AF:
0.0870
Gnomad NFE exome
AF:
0.0573
Gnomad OTH exome
AF:
0.0779
GnomAD4 exome
AF:
0.0647
AC:
94567
AN:
1461864
Hom.:
3886
Cov.:
32
AF XY:
0.0639
AC XY:
46440
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.225
Gnomad4 AMR exome
AF:
0.0853
Gnomad4 ASJ exome
AF:
0.0801
Gnomad4 EAS exome
AF:
0.149
Gnomad4 SAS exome
AF:
0.0476
Gnomad4 FIN exome
AF:
0.0839
Gnomad4 NFE exome
AF:
0.0553
Gnomad4 OTH exome
AF:
0.0767
GnomAD4 genome
AF:
0.110
AC:
16670
AN:
152038
Hom.:
1291
Cov.:
31
AF XY:
0.111
AC XY:
8252
AN XY:
74338
show subpopulations
Gnomad4 AFR
AF:
0.213
Gnomad4 AMR
AF:
0.0917
Gnomad4 ASJ
AF:
0.0758
Gnomad4 EAS
AF:
0.147
Gnomad4 SAS
AF:
0.0529
Gnomad4 FIN
AF:
0.0880
Gnomad4 NFE
AF:
0.0579
Gnomad4 OTH
AF:
0.104
Alfa
AF:
0.0674
Hom.:
939
Bravo
AF:
0.116
Asia WGS
AF:
0.0910
AC:
315
AN:
3478
EpiCase
AF:
0.0612
EpiControl
AF:
0.0606

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016p.Thr221Thr in exon 5 of the NLPR3 gene: This variant is not expected to have cl inical significance because it does not alter an amino acid residue and it has b een identified in 8% (23018/276946) of the total chromosomes by the the Genome A ggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs7525979). -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015This variant is associated with the following publications: (PMID: 30246732, 30131971) -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Familial cold autoinflammatory syndrome 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Cryopyrin associated periodic syndrome Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Familial amyloid nephropathy with urticaria AND deafness Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Chronic infantile neurological, cutaneous and articular syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.026
DANN
Benign
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7525979; hg19: chr1-247587408; COSMIC: COSV60221249; API